Hemp Guardrails Act
Sponsored By: Senator Sheehy, Tim [R-MT]
Introduced
Summary
a federal regulatory framework for hemp-derived cannabinoid products. This bill would create federal rules that redefine hemp, identify restricted intoxicating cannabinoids, and set standards for testing, labeling, manufacturing, age, and origin requirements.
Show full summary
- Families and consumers: Would face a national minimum age of 21 for sales, possession, and consumption. Products must use child-resistant packaging and include a scannable link to test results.
- Farmers and hemp growers: Would see the hemp threshold changed to 1.0 percent total tetrahydrocannabinols concentration including THCA. Process materials that temporarily exceed 1.0 percent could be kept in controlled supply chains if they meet strict possession and use limits.
- Manufacturers, retailers, and supplement makers: Would need facility registration, third-party testing, and good manufacturing practices to sell across states. Dietary supplements with hemp cannabinoids would have to meet both existing supplement rules and the new Chapter XI standards, with those supplement provisions effective December 11, 2026 and core standards due from the Secretary within 180 days.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
5 provisions identified: 0 benefits, 0 costs, 5 mixed.
Hemp THC limit raised to 1%
If enacted, the bill would raise the statutory hemp THC threshold from prior law to 1.0 percent measured as total tetrahydrocannabinols, including THCA. The change would also update USDA and State and Tribal plan language to use the total-THC standard. Hemp growers and processors would face different testing and compliance rules under the new measurement method.
New definitions for hemp products
If enacted, the bill would define which items count as "hemp-derived cannabinoid products" and which do not. It would allow hemp-derived dietary supplements in specified oral and ingestible forms but exclude inhaled or raw floral products from that category. The bill would create rules for "unfinished hemp-cannabinoid ingredients" that may exceed 1.0% total THC only when tightly controlled and not sold at retail.
New safety and age rules for hemp products
If enacted, the bill would set new federal product safety, labeling, and testing rules for hemp-derived cannabinoid products. It would require child-resistant packaging and a QR code or URL linking to third-party test results. The bill would ban sales, possession, and use by people younger than 21 and bar interstate sales of raw floral or smokable hemp and products not finished, packaged, and labeled in the United States. The Secretary would have 180 days after enactment to issue many of these rules and could order recalls and inspections for noncompliant products.
State rules for interstate hemp trade
If enacted, beginning December 11, 2026, States, territories, and Tribes could keep stricter local rules for hemp products but could not block a product that meets the bill’s federal rules from passing through or being delivered across their borders. The provision lets States set protective standards, while protecting interstate movement of federally compliant products.
Hemp supplement rules and Medicare
If enacted, beginning December 11, 2026, hemp-derived cannabinoid dietary supplements would have to meet both dietary supplement rules and the bill’s Chapter XI product requirements. The bill would say such a supplement is not automatically excluded from the dietary supplement definition just because it contains cannabinoids. It would also preserve the Secretary’s authority to run the specified CMS incentive program or allow these supplements as a Medicare supplemental benefit, but it would not require CMS to cover them.
Sponsors & CoSponsors
Sponsor
Sheehy, Tim [R-MT]
MT • R
Cosponsors
Sen. Klobuchar, Amy [D-MN]
MN • D
Sponsored 11/17/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov